Rodouan Touti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rodouan Touti has a total of 151 co-authors. Here are the top co-authors by number of shared publications:
Abdellah Tahiri
Department of Physics, Faculty of Sciences, LISTM, Laboratory Innovation in Sciences, Technologies, and Modeling, Chouaib Doukkali University, El Jadida, Morocco
20 shared publicationsAbdelghafour El Mekkaouy
14 shared publications- Samir Chtita
Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M’Sik, Hassan II University of Casablanca, P.O. Box 7955, Casablanca, Morocco
9 shared publications Mohamed Naji
8 shared publicationsYoussef Didi
8 shared publicationsAdil Moutaouaffiq
7 shared publications
Latest Publications
- 13 October 2026
- Published by Springer Nature in Chemistry Africa
- Vol. 9 (9) , 377
First-Principles Investigation of the Structural, Physical, and Radiation Shielding Properties of FrZnX3 (X = F, I) Perovskites
- 13 October 2026
- Published by Springer Nature in Chemistry Africa
- Vol. 9 (9) , 377
First-Principles Investigation of the Structural, Physical, and Radiation Shielding Properties of FrZnX3 (X = F, I) Perovskites
- 13 October 2026
- Published by Springer Nature in Chemistry Africa
- Vol. 9 (9) , 376
Experimental and Theoretical Investigation of the Structural, Dielectric, Electronic, and Mechanical Properties of Gd-doped BaTiO₃ for Photocatalytic Applications
- 13 October 2026
- Published by Springer Nature in Chemistry Africa
- Vol. 9 (9) , 376
Experimental and Theoretical Investigation of the Structural, Dielectric, Electronic, and Mechanical Properties of Gd-doped BaTiO₃ for Photocatalytic Applications
- 9 October 2026
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 252
Localization-dependent DNA damage in nanoparticle-enhanced radiotherapy: A mesh-volume multi-scale Monte Carlo study
- 9 October 2026
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 252
Localization-dependent DNA damage in nanoparticle-enhanced radiotherapy: A mesh-volume multi-scale Monte Carlo study
- 10 September 2026
- Published by Elsevier in Physica B: Condensed Matter
- Vol. 742
Electric field-driven modulation of optical properties of a shallow donor in a GaAs/Ga1−xAlxAs pillbox surrounded by Ga1−yAlyAs
- 10 September 2026
- Published by Elsevier in Physica B: Condensed Matter
- Vol. 742
Electric field-driven modulation of optical properties of a shallow donor in a GaAs/Ga1−xAlxAs pillbox surrounded by Ga1−yAlyAs
- 7 August 2026
- Published by Elsevier in Current Applied Physics
- Vol. 91, 92-100
Wetting layer-controlled donor binding energy and photoionization cross section for tunable optoelectronic response in lens-shaped quantum dots
- 7 August 2026
- Published by Elsevier in Current Applied Physics
- Vol. 91, 92-100
Wetting layer-controlled donor binding energy and photoionization cross section for tunable optoelectronic response in lens-shaped quantum dots
- Open Access
- 10 July 2026
- Published by Elsevier in SSRN Electronic Journal
Electric Field-Driven Modulation of Optical Properties of a Shallow Donor in a GaAs/Ga₁₋ₓAlₓAs Pillbox Surrounded by Ga₁₋ᵧAlᵧAs
This research explores how an electric field (F) influences the optical absorption coefficients (OACs) and the relative refractive index (RI) of a donor impurity confined in a GaAs/Ga₁₋ₓAlₓAs pillbox immersed in a Ga₁₋ᵧAlᵧAs matrix (PQD). To perform these calculations, we used a variational approach within the effective mass approximation (EMA) framework. Our findings show that a growth-axis electric field distorts the electronic wave function, thereby tuning the energy spectrum and optical transition probabilities. This leads to peak shifts and notable amplitude variations in the relative RI changes, and likewise in the linear and nonlinear OACs. Furthermore, reducing barrier thickness enhances quantum confinement and alters the resonance positions, while higher incident intensity amplifies third-order nonlinear contributions, reshaping the overall optical response. These outcomes confirm precise optical tunability through electric field, barrier design, and intensity, opening new avenues for tunable optoelectronic nanodevices.
- 10 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessElectric Field-Driven Modulation of Optical Properties of a Shallow Donor in a GaAs/Ga₁₋ₓAlₓAs Pillbox Surrounded by Ga₁₋ᵧAlᵧAs
This research explores how an electric field (F) influences the optical absorption coefficients (OACs) and the relative refractive index (RI) of a donor impurity confined in a GaAs/Ga₁₋ₓAlₓAs pillbox immersed in a Ga₁₋ᵧAlᵧAs matrix (PQD). To perform these calculations, we used a variational approach within the effective mass approximation (EMA) framework. Our findings show that a growth-axis electric field distorts the electronic wave function, thereby tuning the energy spectrum and optical transition probabilities. This leads to peak shifts and notable amplitude variations in the relative RI changes, and likewise in the linear and nonlinear OACs. Furthermore, reducing barrier thickness enhances quantum confinement and alters the resonance positions, while higher incident intensity amplifies third-order nonlinear contributions, reshaping the overall optical response. These outcomes confirm precise optical tunability through electric field, barrier design, and intensity, opening new avenues for tunable optoelectronic nanodevices.
- Open Access
- 7 July 2026
- Published by Elsevier in Scientific African
- Vol. 33
Design and Interfacial Optimization of a High-Efficiency Cu2O/In2S3 Heterojunction Thin-Film Solar Cell
- 7 July 2026
- Published by Elsevier in Scientific African
- Vol. 33
Open AccessDesign and Interfacial Optimization of a High-Efficiency Cu2O/In2S3 Heterojunction Thin-Film Solar Cell
- Open Access
- 24 June 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 5696
In Silico Design of Pyrimidine Derivatives as Potential α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Studies
Diabetes mellitus remains a major metabolic disorder requiring the development of new and effective α-glucosidase inhibitors. The present study aimed to identify, design, and optimize novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-α]pyrimidine derivatives with promising inhibitory activity against the α-glucosidase enzyme using a comprehensive in silico strategy. Approximately 300 molecular descriptors were calculated to characterize a dataset of 32 compounds (Peytam et al.) and to investigate the structural factors governing their biological activity. Based on these descriptors, a multiple linear regression model was developed to predict the inhibitory activities of the compounds against alpha-glucosidase. The developed model demonstrated satisfactory predictive performance and was internally and externally validated to ensure its accuracy, robustness, and reproducibility. In addition, the applicability domain analysis confirmed the reliability of the predictions. Using the validated QSAR model, seven new derivatives were designed with predicted pIC50 values exceeding the maximum activity of the parent compounds. The leverage analysis demonstrated that all newly designed compounds were located within the applicability domain of the model, supporting the reliability of the predictions. To further evaluate their inhibitory potential, molecular docking studies were performed to investigate the interactions between the designed compounds and the α-glucosidase active site. The docking results revealed favorable binding interactions comparable to those reported for known α-glucosidase inhibitors. Furthermore, ADMET analysis indicated generally favorable pharmacokinetic properties, although potential CYP3A4 inhibition-related pharmacokinetic risks were identified and discussed. Molecular dynamics simulations, including replicated runs and MM/GBSA binding free energy calculations, confirmed the stability of the most promising protein–ligand complexes throughout the simulation period. In conclusion, this study proposes a robust and integrated computational workflow combining descriptor generation, QSAR modeling, applicability domain analysis, molecular docking, ADMET prediction, and molecular dynamics simulations for the rational design of potential α-glucosidase inhibitors. The findings highlight the therapeutic potential of the designed derivatives and provide a valuable in silico framework for the future development of antidiabetic agents.
- 24 June 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 5696
Open AccessIn Silico Design of Pyrimidine Derivatives as Potential α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Studies
Diabetes mellitus remains a major metabolic disorder requiring the development of new and effective α-glucosidase inhibitors. The present study aimed to identify, design, and optimize novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-α]pyrimidine derivatives with promising inhibitory activity against the α-glucosidase enzyme using a comprehensive in silico strategy. Approximately 300 molecular descriptors were calculated to characterize a dataset of 32 compounds (Peytam et al.) and to investigate the structural factors governing their biological activity. Based on these descriptors, a multiple linear regression model was developed to predict the inhibitory activities of the compounds against alpha-glucosidase. The developed model demonstrated satisfactory predictive performance and was internally and externally validated to ensure its accuracy, robustness, and reproducibility. In addition, the applicability domain analysis confirmed the reliability of the predictions. Using the validated QSAR model, seven new derivatives were designed with predicted pIC50 values exceeding the maximum activity of the parent compounds. The leverage analysis demonstrated that all newly designed compounds were located within the applicability domain of the model, supporting the reliability of the predictions. To further evaluate their inhibitory potential, molecular docking studies were performed to investigate the interactions between the designed compounds and the α-glucosidase active site. The docking results revealed favorable binding interactions comparable to those reported for known α-glucosidase inhibitors. Furthermore, ADMET analysis indicated generally favorable pharmacokinetic properties, although potential CYP3A4 inhibition-related pharmacokinetic risks were identified and discussed. Molecular dynamics simulations, including replicated runs and MM/GBSA binding free energy calculations, confirmed the stability of the most promising protein–ligand complexes throughout the simulation period. In conclusion, this study proposes a robust and integrated computational workflow combining descriptor generation, QSAR modeling, applicability domain analysis, molecular docking, ADMET prediction, and molecular dynamics simulations for the rational design of potential α-glucosidase inhibitors. The findings highlight the therapeutic potential of the designed derivatives and provide a valuable in silico framework for the future development of antidiabetic agents.